By moving around, some cancer cells force attacking immune cells to just nibble at the edges rather than engulf them ...
Bell Labs is already highly recognized, but in its centennial year, the organization hoped to add more awards to burnish its ...
Science moves forward on data. We all know this. But bad data leads science down dead ends. It wastes time. It wastes money.
A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...
Every winter, as the air sharpens and scarves return to shoulders, an old visitor also makes a reappearance: the flu. It ...
The cells of all animals—including humans—are characterized by their ability to adhere particularly well to surfaces in their ...
Scientists have captured an unprecedented, real-time view of influenza viruses as they move across and slip inside human ...
A new stem cell–based therapy challenges traditional pain treatment by using pain-sensing neurons to reduce inflammation and protect joints. Newly released preclinical data describes an unconventional ...
Pipettes? Check. Centrifuges? Check. Microplates? Check. Gloves? Check. Salmon sperm DNA? Check. Wait what? There are a ...
The study presents convincing quantitative evidence, supported by appropriate negative controls, for the presence of low-abundance glycine receptors (GlyRs) within inhibitory synapses in telencephalic ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on a novel approach to chronic pain management and joint tissue preservation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results